Fellowship · Royal Oak, MI
Sponsored by Corewell Health
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 1,863 citations · Ishmael Jaiyesimi
Treatment of Metastatic Colorectal Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 549 citations · Ishmael Jaiyesimi
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 263 citations · Ishmael Jaiyesimi
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 364 citations · Ishmael Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 264 citations · Ishmael Jaiyesimi
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 83 citations · Ishmael Jaiyesimi
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.
JAMA oncology · 2024 · 59 citations · Dana Zakalik
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 117 citations · Ishmael Jaiyesimi